Wayne Burt Pharma Labs Limited - Company Profile

It is a business services public limited company based in Chennai, Tamil Nadu, India, established in 2015.
2015 Chennai, Tamil Nadu, India Struck Off
Last Updated:
Access Report
About Wayne Burt Pharma Labs Limited

Wayne Burt Pharma Labs Limited, a struck off public limited company, was established on 25 May 2015 in Chennai, Tamil Nadu, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74900TN2015PLC100637. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.53 M.

Its leadership includes Subramanian Venkatraman (Director), Triplicani Gowrishankar Mahesh (Director), Krishnan Rangamani (Director). It is based at No 145, 2Nd Main Road,Rangareddy Gardens, Neelangarai, Chennai, Tamil Nadu, 600041.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900TN2015PLC100637

  • Registration Number

    100637

  • Incorporation Date

    25 May 2015

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.53 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.53 M
  • Company Age 10 Year, 8 Months
Company report

Wayne Burt Pharma Labs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Wayne Burt Pharma Labs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Wayne Burt Pharma Labs Limited?
Current Directors
Name Designation Appointment Date Status
Subramanian Venkatraman Director 25 May 2015 Current
Triplicani Gowrishankar Mahesh Director 25 May 2015 Current
Krishnan Rangamani Director 25 May 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Wayne Burt Pharma Labs.

Enhance accessibility to Wayne Burt Pharma Labs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Wayne Burt Pharma Labs revenue growth over time
Wayne Burt Pharma Labs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Wayne Burt Pharma Labs?

Unlock access to Wayne Burt Pharma Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Wayne Burt Pharma Labs?

Unlock and access historical data on people associated with Wayne Burt Pharma Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Wayne Burt Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wayne Burt Pharma Labs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Wayne Burt Pharma Labs
Recent Activity within the Organization
  • Director Appointment

    Progress on Subramanian Venkatraman was appointed as a Director was appointed as a Director on 25 May 2015 & has been associated with this company since 10 years 8 months . was documented.

  • Director Appointment

    The activity Triplicani Gowrishankar Mahesh was appointed as a Director was appointed as a Director on 25 May 2015 & has been associated with this company since 10 years 8 months . was completed.

  • Director Appointment

    The activity Krishnan Rangamani was appointed as a Director was appointed as a Director on 25 May 2015 & has been associated with this company since 10 years 8 months . was completed.

  • Company Incorporation

    Progress on Wayne Burt Pharma Labs Limited was registered on 25 May 2015 with Roc Chennai & aged 10 years 8 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Wayne Burt Pharma Labs Limited?

The CIN of Wayne Burt Pharma Labs Limited is U74900TN2015PLC100637.

Where is Wayne Burt Pharma Labs Limited headquartered?

Wayne Burt Pharma Labs Limited is headquartered at No 145, 2Nd Main Road,Rangareddy Gardens, Neelangarai, Chennai, Tamil Nadu, 600041.

When was Wayne Burt Pharma Labs Limited incorporated?

Wayne Burt Pharma Labs Limited was incorporated on 25 May 2015.

Who are the current directors of Wayne Burt Pharma Labs Limited?

The current directors of Wayne Burt Pharma Labs Limited are

What is the primary industry of Wayne Burt Pharma Labs Limited?

The primary industry of Wayne Burt Pharma Labs Limited is Business Services.

Is Wayne Burt Pharma Labs Limited a listed company?

Wayne Burt Pharma Labs Limited is unlisted.

What is the capital structure of Wayne Burt Pharma Labs Limited?

The authorized capital of Wayne Burt Pharma Labs Limited is ₹1.00 M, and the paid-up capital is ₹0.53 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available